Identifying patients with Crohn's disease at high risk of primary nonresponse to infliximab using a radiomic-clinical model.

Xuehua Li Yingkui Zhong Chenglang Yuan Jinjiang Lin Xiaodi Shen Minyi Guo Baolan Lu Jixin Meng Yangdi Wang Naiwen Zhang Zixin Luo Guimeng Hu Ren Mao Minhu Chen Canhui Sun Ziping Li Qing-hua Cao Baili Chen Zhihui Chen Bingsheng Huang Shi-Ting Feng

Published in: Int. J. Intell. Syst. (2022)

Keyphrases